199 related articles for article (PubMed ID: 25961466)
1. Regulation and function of P-Rex family Rac-GEFs.
Welch HC
Small GTPases; 2015; 6(2):49-70. PubMed ID: 25961466
[TBL] [Abstract][Full Text] [Related]
2. Rac signaling in breast cancer: a tale of GEFs and GAPs.
Wertheimer E; Gutierrez-Uzquiza A; Rosemblit C; Lopez-Haber C; Sosa MS; Kazanietz MG
Cell Signal; 2012 Feb; 24(2):353-362. PubMed ID: 21893191
[TBL] [Abstract][Full Text] [Related]
3. Structural basis of membrane targeting by the Dock180 family of Rho family guanine exchange factors (Rho-GEFs).
Premkumar L; Bobkov AA; Patel M; Jaroszewski L; Bankston LA; Stec B; Vuori K; Côté JF; Liddington RC
J Biol Chem; 2010 Apr; 285(17):13211-22. PubMed ID: 20167601
[TBL] [Abstract][Full Text] [Related]
4. Structural and dynamic changes in P-Rex1 upon activation by PIP
Ravala SK; Adame-Garcia SR; Li S; Chen CL; Cianfrocco MA; Gutkind JS; Cash JN; Tesmer JJG
bioRxiv; 2024 Apr; ():. PubMed ID: 37745379
[TBL] [Abstract][Full Text] [Related]
5. The Phosphatidylinositol (3,4,5)-Trisphosphate-dependent Rac Exchanger 1·Ras-related C3 Botulinum Toxin Substrate 1 (P-Rex1·Rac1) Complex Reveals the Basis of Rac1 Activation in Breast Cancer Cells.
Lucato CM; Halls ML; Ooms LM; Liu HJ; Mitchell CA; Whisstock JC; Ellisdon AM
J Biol Chem; 2015 Aug; 290(34):20827-20840. PubMed ID: 26112412
[TBL] [Abstract][Full Text] [Related]
6. Heregulin/ErbB3 Signaling Enhances CXCR4-Driven Rac1 Activation and Breast Cancer Cell Motility via Hypoxia-Inducible Factor 1α.
Lopez-Haber C; Barrio-Real L; Casado-Medrano V; Kazanietz MG
Mol Cell Biol; 2016 Aug; 36(15):2011-26. PubMed ID: 27185877
[TBL] [Abstract][Full Text] [Related]
7. p21-activated Kinases (PAKs) Mediate the Phosphorylation of PREX2 Protein to Initiate Feedback Inhibition of Rac1 GTPase.
Barrows D; Schoenfeld SM; Hodakoski C; Silkov A; Honig B; Couvillon A; Shymanets A; Nürnberg B; Asara JM; Parsons R
J Biol Chem; 2015 Nov; 290(48):28915-31. PubMed ID: 26438819
[TBL] [Abstract][Full Text] [Related]
8. Endothelial RhoGEFs: A systematic analysis of their expression profiles in VEGF-stimulated and tumor endothelial cells.
Hernández-García R; Iruela-Arispe ML; Reyes-Cruz G; Vázquez-Prado J
Vascul Pharmacol; 2015 Nov; 74():60-72. PubMed ID: 26471833
[TBL] [Abstract][Full Text] [Related]
9. Phosphatidylinositol (3,4) bisphosphate-specific phosphatases and effector proteins: A distinct branch of PI3K signaling.
Li H; Marshall AJ
Cell Signal; 2015 Sep; 27(9):1789-98. PubMed ID: 26022180
[TBL] [Abstract][Full Text] [Related]
10. P-Rex1 Expression in Invasive Breast Cancer in relation to Receptor Status and Distant Metastatic Site.
Marotti JD; Muller KE; Tafe LJ; Demidenko E; Miller TW
Int J Breast Cancer; 2017; 2017():4537532. PubMed ID: 28698809
[TBL] [Abstract][Full Text] [Related]
11. ERK/MAPK Signaling Drives Overexpression of the Rac-GEF, PREX1, in BRAF- and NRAS-Mutant Melanoma.
Ryan MB; Finn AJ; Pedone KH; Thomas NE; Der CJ; Cox AD
Mol Cancer Res; 2016 Oct; 14(10):1009-1018. PubMed ID: 27418645
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms for spatiotemporal regulation of Rho-GTPase signaling at synapses.
Duman JG; Mulherkar S; Tu YK; X Cheng J; Tolias KF
Neurosci Lett; 2015 Aug; 601():4-10. PubMed ID: 26003445
[TBL] [Abstract][Full Text] [Related]
13. Rap1 Spatially Controls ArhGAP29 To Inhibit Rho Signaling during Endothelial Barrier Regulation.
Post A; Pannekoek WJ; Ponsioen B; Vliem MJ; Bos JL
Mol Cell Biol; 2015 Jul; 35(14):2495-502. PubMed ID: 25963656
[TBL] [Abstract][Full Text] [Related]
14. P-Rex1 and P-Rex2 RacGEFs and cancer.
Srijakotre N; Man J; Ooms LM; Lucato CM; Ellisdon AM; Mitchell CA
Biochem Soc Trans; 2017 Aug; 45(4):963-77. PubMed ID: 28710285
[TBL] [Abstract][Full Text] [Related]
15. Novel insights into immune-related genes associated with type 2 diabetes mellitus-related cognitive impairment.
Gao J; Zou Y; Lv XY; Chen L; Hou XG
World J Diabetes; 2024 Apr; 15(4):735-757. PubMed ID: 38680704
[TBL] [Abstract][Full Text] [Related]
16. PREX2 contributes to radiation resistance by inhibiting radiotherapy-induced tumor immunogenicity via cGAS/STING/IFNs pathway in colorectal cancer.
Li M; Xiao J; Song S; Han F; Liu H; Lin Y; Ni Y; Zeng S; Zou X; Wu J; Wang F; Xu S; Liang Y; Xu P; Hong H; Qiu J; Cao J; Zhu Q; Liang L
BMC Med; 2024 Apr; 22(1):154. PubMed ID: 38609982
[TBL] [Abstract][Full Text] [Related]
17. Resolving the role of podoplanin in the motility of papillary thyroid carcinoma-derived cells using RNA sequencing.
Mielecki D; Gajda E; Sikorska J; Betkowska A; Rozwadowski M; Gawel AM; Kulecka M; Zeber-Lubecka N; Godlewska M; Gawel D
Comput Struct Biotechnol J; 2023; 21():3810-3826. PubMed ID: 37560122
[TBL] [Abstract][Full Text] [Related]
18. Dock2 generates characteristic spatiotemporal patterns of Rac activity to regulate neutrophil polarisation, migration and phagocytosis.
Machin PA; Johnsson AE; Massey EJ; Pantarelli C; Chetwynd SA; Chu JY; Okkenhaug H; Segonds-Pichon A; Walker S; Malliri A; Fukui Y; Welch HCE
Front Immunol; 2023; 14():1180886. PubMed ID: 37383235
[TBL] [Abstract][Full Text] [Related]
19. Role of RhoG as a regulator of cellular functions: integrating insights on immune cell activation, migration, and functions.
Rai SK; Singh D; Sarangi PP
Inflamm Res; 2023 Jul; 72(7):1453-1463. PubMed ID: 37378671
[TBL] [Abstract][Full Text] [Related]
20. P-Rex1 is a novel substrate of the E3 ubiquitin ligase Malin associated with Lafora disease.
Kumarasinghe L; Garcia-Gimeno MA; Ramirez J; Mayor U; Zugaza JL; Sanz P
Neurobiol Dis; 2023 Feb; 177():105998. PubMed ID: 36638890
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
